Skip to main content
Center for Genetics and Society logo

Follow us on Facebook Follow us on Twitter Follow us on YouTube

Main navigation

  • home
  • Publications
  • Topics
  • Press
  • About

Search

  • Search
  • Donate
  • Subscribe

'Altered Nuclear Transfer-ANT' Crosses Ethical Boundaries [PDF]

By International Center for Technology Assessment | 12. 03. 2004

Perspectives

Serial Entrepreneur and “Frankenstein’s” Ex Launches (Another) New Germline Editing Startup

By Pete Shanks | 03.26.2026
Policies

Public Health, Vaccines and Modern Eugenics

By Pete Shanks | 02.27.2026
Bioethics

The Shameful Legacy of Tuskegee Is Still Relevant

By Pete Shanks | 01.28.2026
U.S. Federal

Good Trouble

By Pete Shanks | 12.18.2025
Society

Aggregated News

U.S. Federal
Assisted Reproduction
Human Cloning
Biopolitics
Fact Sheets

Related Articles

Surrogacy goes more mainstream

By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026

Aggregated News

More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.

Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...

U.S. Federal

Surrogacy laws are all over the map

By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026

Aggregated News

Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/

Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...

Policies

Serial Entrepreneur and “Frankenstein’s” Ex Launches (Another) New Germline Editing Startup

By Pete Shanks | 03.26.2026
Biopolitical Times

Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as: 

Get in luddite, we’re going gene editing...

Policies

Genome editing’s third act

By Laura DeFrancesco, Nature Biotechnology | 03.17.2026

Aggregated News

The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...

Human Genetic Modification

Footer

  • Publications
  • Topics
  • Press
  • About
  • Contact

subscribe

The Center for Genetics and Society is fiscally sponsored by Tides Center, a 501(c)(3) non-profit organization.
Please visit www.tides.org/state-nonprofit-disclosures for additional information.

© 2023 Tides Center, through the Center for Genetics and Society. All rights reserved.
Privacy Policy. Terms of Use.